A Multinational, Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, 2x2 Factorial Design Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes

  • Reynolds, L (PI)
  • Rudy, David (CoI)
  • Fanti, Paolo (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/024/30/06

Funding

  • Novartis (domestic): $47,899.00